OpenCalais Metadata: Ticker
OpenCalais Metadata: LegalName
Turkey has started to administer its homegrown COVID-19 vaccine candidate to volunteers at a major hospital in the capital Ankara as part of the jab's Phase 3 clinical trials to compare its efficacy to that of the Chinese-developed CoronaVac shot, the country's top health official announced on July 16.
Despite the success of the ongoing vaccination program, COVID-19 cases are on the rise, but presently there is no need to impose restrictions, Health Minister Fahrettin Koca has said.
Data from the Health Ministry show that the daily virus cases inched up above 6,000 cases over the last couple of days after plateauing to around 5,000 in the past weeks.
Turkey will receive 12 million doses of a COVID-19 vaccine developed by Pfizer/BioNTech by the end of next week, the country's health minister has said.
Fahrettin Koca said he spoke with Uğur Şahin, the co-founder of CEO of Germany-based BioNTech, earlier this week and that Şahin confirmed that they obtained export permission for 12 million doses of the injection.
Turkey has signed an agreement for the procurement of over 90 million doses of the Pfizer/BioNTech COVID-19 vaccines, the country's Health Minister has said.
In June, some 30 million doses of the Pfizer/BioNTech jabs will arrive in Turkey, and the deliveries will continue in July, August, and September, Fahrettin Koca told reporters.